These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11405217)

  • 1. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H; Dietrich G; Kaufmann SH
    Biol Chem; 2001 Apr; 382(4):521-32. PubMed ID: 11405217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent role of vaccines prepared from macrophages infected with live bacteria in protection against Mycobacterium tuberculosis and Salmonella typhimurium infections.
    Sharma N; Agrewala JN
    J Infect Dis; 2004 Jul; 190(1):107-14. PubMed ID: 15195249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK
    Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D; Weidinger G; Spreng S
    Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving live attenuated bacterial carriers for vaccination and therapy.
    Loessner H; Endmann A; Leschner S; Bauer H; Zelmer A; zur Lage S; Westphal K; Weiss S
    Int J Med Microbiol; 2008 Jan; 298(1-2):21-6. PubMed ID: 17702649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
    Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
    Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.
    Dietrich G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):177-82. PubMed ID: 10912622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of bacterial vector technology.
    Kochi SK; Killeen KP; Ryan US
    Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine.
    Pascual DW; Powell RJ; Lewis GK; Hone DM
    Behring Inst Mitt; 1997 Feb; (98):143-52. PubMed ID: 9382735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the development of live, attenuated bacterial vectors.
    Roland KL; Tinge SA; Killeen KP; Kochi SK
    Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J; Vipond R; Allen-Vercoe E; Clark SO; Hatch GJ; Gooch KE; Bacon J; Hampshire T; Shuttleworth H; Minton NP; Blake K; Williams A; Marsh PD
    Vaccine; 2006 Sep; 24(37-39):6340-50. PubMed ID: 16781800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current tuberculosis vaccine development.
    Young DB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S254-6. PubMed ID: 10875794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines against mycobacterial diseases.
    Romano M; Huygen K
    Expert Rev Vaccines; 2009 Sep; 8(9):1237-50. PubMed ID: 19722896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella enterica as a vaccine carrier.
    Hegazy WA; Hensel M
    Future Microbiol; 2012 Jan; 7(1):111-27. PubMed ID: 22191450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.